Navigation Links
New dimension in the treatment of female sexual dysfunction

Female sexual dysfunction is associated with loss of libido, low motivation and fatigue, most often occurring in women who have attained their menopause or whose ovaries had been removed surgically for some reason.

Dehydroepiandosterone(DHEA), may serve as an effective treatment in such sexual dysfunction, according to a study released at the 96th annual meeting of the American Urological Association in Anaheim, California. This report was the end result of the study done by Irwin Goldstein MD, and colleagues from Boston University School of Medicine who administered DHEA to 32 patients.

Long-term risks of androgen replacement therapy are not known. Dr. Goldstein and colleagues note that more research is needed to determine whether women with sexual dysfunction should receive this treatment.
'"/>




Page: 1

Related medicine news :

1. Primates reveal a new dimension to human genome
2. Three dimensional structure of apolipoprotein revealed
3. A three-dimensional Culture System ensures Female Fertility
4. Thyroid hormone treatment hastens recovery after cardiac surgery
5. Feeding channel created by malaria parasite - a new target for malaria treatments
6. Now umbilical cord helps in stroke treatment.
7. Now AIDS treatment comes dirt-cheap
8. Breast cancer treatment to be determined by gene test
9. Hemopurifier may revolutionise AIDS treatment
10. New drug helps boost cancer treatment
11. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ccording to the World Health Organization (WHO) ex...tment is necessary for complete eradication of the...Asia in the next five-ten // years. WHO has ident...lymphatic filariasis (LF), visceral leishmaniasis ...
...n a step which is expected to alleviate the nation...rsing professors, allowing nursing schools to enro...n has awarded // $995,000 to the Medical College o... its new doctorate of nursing practice program, th...
...cientists in past centuries called the sickness by... the supposedly disease-bearing zephyrs wafting fr...spread by mosquitos. // And they say ill winds are...o halt the spread of a disease that kills 1 millio...
...he state-run Indira Gandhi Medical College (IGMC) ...s on patients in Himachal Pradesh. 'The IGMC hospi...st equipment including light monitoring system, li... light, automatic operation bed and latest x-ray m...
Other Medicine News:Health News:Concerted Effort Imperative For Elimination Of Tropical Diseases: WHO 2Health News:Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program 2Health News:Malaria Vaccine May Be 10 Years Away 2Health News:Malaria Vaccine May Be 10 Years Away 3
(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008)...taq(R) (dronedarone) decreased the risk of,stroke ...al flutter already adequately treated...pt. 3 /- The results of a,p... were presented today at,the clinical trial update...gress 2008, in Munich, Germany. Previous results f...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/2/2008)...re-FirstCall/ -- Forest Laboratories, Inc.,(NYSE: ...nced results from,two global Phase III studies of ...ticholinergic for the treatment of patients with c...th the ACCLAIM/COPD I&II,(AClidinium CLinical Tria...ere COPD Patients) studies, once-daily aclidinium ...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 1AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 2AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 1Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 2Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 4Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 1Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 2Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 3Spiritual Healer Psychic Medium Reaches International Status 21 1230 1Spiritual Healer Psychic Medium Reaches International Status 21 1230 2
... Nasalfent shows clinically meaningful pain relief..., READING, England, 7 June 2007 - Archimedes Pharm...eutical company, today,presented new clinical data...ive fentanyl citrate nasal spray aimed at providin...reakthrough cancer,pain. Data were presented at th...
...Orexigen(TM) is evaluating zonisamide SR as a nove..., SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ ...utical company focused on the,treatment of central... obesity, today announced results from a Phase I t... novel, proprietary,sustained-release (SR) formul...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
The Vitek is a completely automated instrument that offers Rapid results (with an average of 2 - 6 hour same day turnaround), random or batch processing and a quality control module. It is used for b
IDS Rapid One, a microbial identification system.
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in
The SkanWasher 300 is an automatic 96-well microplate washer designed to give reliable, reproducible results, with no cross-contamination between wells, and no carryover from plate to plate. The wash
Medicine Products: